Ticker: CSBR

Champions Oncology, Inc. (NASDAQ: CSBR) - Quarterly snapshot (Q1 ended July 31, 2025) Quick take: revenue stable but rising costs and R&D investment turned a small profitable quarter last year into a net loss this quarter. Cash generation is positive but working capital is negative and the compan...

Company Overview: Champions Oncology, Inc. (NASDAQ: CSBR) is a technology-enabled research organization focused on oncology services, providing drug discovery and development solutions through its innovative platforms, including pharmacology services and translational oncology solutions (TOS). Ke...